Sequenom is the trusted source for genetic testing that guides reproductive health matters. The Company is dedicated to delivering the most advanced genetic testing solutions available to provide answers that assist parents and physicians in proactively addressing informed family planning.

Sequenom offers the broadest collection of carrier status, NIPT, and diagnostic test options—from assessing a baby’s whole genome to detecting specific conditions—so that parents and physicians can select the right test for each pregnancy.

Parent Company
Laboratory Corporation of America Holdings
San Diego, US
Sequenom was founded in 1994 and is headquartered in San Diego, US

Sequenom Office Locations

Sequenom has offices in San Diego, Salt Lake City, New York, Philadelphia and in 17 other locations
San Diego, US (HQ)
3595 John Hopkins Ct
Show all (21)

Sequenom Data and Metrics

Sequenom Summary

Founding Date


Total Funding

$183.1 m
Sequenom is a subsidiary of Laboratory Corporation of America Holdings

Sequenom Financial Metrics

Sequenom's revenue was reported to be $128.3 m in FY, 2015 which is a 15% decrease from the previous period.
USDFY, 2013FY, 2014FY, 2015


162.4 m151.6 m128.3 m

Revenue growth, %


Cost of goods sold

102.7 m83.5 m67 m

Gross profit

59.7 m68.1 m61.3 m

Gross profit Margin, %


R&D expense

25 m

General and administrative expense

46.9 m

Operating expense total

158.1 m104.6 m157.9 m


(98.4 m)(13.7 m)(7.9 m)

EBIT margin, %


Interest expense

8.4 m8.2 m8.1 m

Interest income

55 k71 k

Pre tax profit

(107.1 m)(22 m)(16.1 m)

Income tax expense

(301 k)(7.7 m)(244 k)

Net Income

(107.4 m)1 m(16.3 m)
USDFY, 2013FY, 2014FY, 2015


61.6 m63.3 m50.3 m

Accounts Receivable

10.2 m9.1 m6.4 m


17 m6.5 m2.4 m

Current Assets

101.5 m121.7 m89 m


10 m10 m10 m

Total Assets

144.7 m161.1 m118.8 m

Accounts Payable

10 m6.1 m5.2 m

Current Liabilities

49.6 m56 m21.5 m

Additional Paid-in Capital

967 m981.9 m991 m

Retained Earnings

(1 b)(1 b)(1 b)

Total Equity

(31.2 m)(38.4 m)

Financial Leverage

-5.2 x-3.1 x
USDFY, 2013FY, 2014FY, 2015

Net Income

(107.4 m)1 m(16.3 m)

Depreciation and Amortization

15.1 m12.2 m

Accounts Receivable

(2.3 m)(6.6 m)


(6.2 m)5.1 m

Accounts Payable

(90 k)(5.7 m)

Cash From Operating Activities

(85.6 m)(28.1 m)(13 m)

Cash From Investing Activities

29.4 m32.9 m

Cash From Financing Activities

(6.1 m)(5.7 m)

Interest Paid

7.4 m7.1 m

Sequenom Online and Social Media Presence

Sequenom News and Updates

Sequenom Company Life and Culture

You may also be interested in